CLINICAL_TRIALS
trial_result
· 2019-01-29
Clinical Trial Update: Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing [Phase 4]
Summary
Phase 4 trial comparing dosing regimens of acetazolamide for prevention of acute mountain sickness has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Utah | Conditions: Prophylaxis of Acute Mountain Sickness | Phase 4 | Status: COMPLETED | Results posted: 2019-01-29